Merck Nobivac 5-way Vaccine Canine 1-DAPPv

Merck

Canine 1-DAPPv

A proven foundation for vaccine protocols. Canine 1-DAPPv is a combination vaccine approved for protection against canine distemper virus, adenovirus type 1 and 2, canine parainfluenza virus, and canine parvovirus.

Protects against all known strains of CPV, including CPV-2c^2,3
High antigenic mass (titer), low passage parvovirus vaccine
Canine vaccine containing CPV-2b, one of the most prevalent field strains of parvovirus
Protects against 2 types of adenovirus that cause hepatitis and respiratory disease in dogs
Provides disease coverage for commonly spread canine viruses, distemper, adenovirus types 1 and 2, parainfluenza and parvovirus in 1 formula
First to publish data showing protection against CPV-2c challenge²
Multiple studies demonstrate the ability to override maternal antibodies¹

NOBIVAC^® CANINE 1-DAPPv PROVIDES PROTECTION AGAINST:

Canine Distemper Virus, Canine Adenovirus type 1, Canine Adenovirus type 2, Canine Parainfluenza Virus, Canine Parvovirus (modified live viruses).

INDICATIONS:

Shown to be effective for the vaccination against canine distemper virus, canine adenovirus type 1 (hepatitis), canine adenovirus type 2 (respiratory disease), canine parainfluenza virus and canine parvovirus.

ADMINISTRATION AND DOSAGE

Subcutaneous or intramuscular injection
Primary vaccination may begin as early as 6 weeks
Repeat dose at 2 to 4 weeks later.
Two doses are required for primary immunization.
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.
Available in a 25 x 1 mL dose presentation